SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-23-273614
Filing Date
2023-11-08
Accepted
2023-11-08 16:59:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d581261dsc13da.htm SC 13D/A 40188
  Complete submission text file 0001193125-23-273614.txt   41457
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 231389028
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER CA 08807
Business Address
Patel Chintu (Filed by) CIK: 0001737428 (see all company filings)

Type: SC 13D/A